Mosunetuzumab plus polatuzumab vedotin in transplant-ineligible refractory/relapsed large B-cell lymphoma: primary results of the phase 3 SUNMO trial.

Budde L. E., Zhang H., Kim W., Maruyama D., Rego E. M., Norasetthada L., ...Daha Fazla

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2025 (SCI-Expanded)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası:
• Basım Tarihi: 2025
• Doi Numarası: 10.1200/jco-25-01957
• Dergi Adı: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, Gender Studies Database, International Pharmaceutical Abstracts, Veterinary Science Database, Nature Index
• Ankara Üniversitesi Adresli: Evet